Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TNXP

Tonix Pharmaceuticals Holding Corp

Dec 12 • 11:33AM ET

0.2359

Dollar change +0.0337
Percentage change 16.67	%

Healthcare • Biotechnology • USA • NASD

Peers: SAVA GERN DRRX ACHV VNDA EPIX CYCC SNPX SLRX

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-20.56	Insider Own	0.00%	Shs Outstand	186.89M	Perf Week	36.75%
Market Cap	44.09M	Forward P/E	-	EPS next Y	-14.11	Insider Trans	-	Shs Float	186.89M	Perf Month	62.69%
Income	-135.25M	PEG	-	EPS next Q	-3.90	Inst Own	1.51%	Short Float	0.85%	Perf Quarter	50.45%
Sales	11.29M	P/S	3.91	EPS this Y	33.36%	Inst Trans	256.62%	Short Ratio	0.05	Perf Half Y	-78.36%
Book/sh	0.48	P/B	0.49	EPS next Y	23.09%	ROA	-115.46%	Short Interest	1.59M	Perf Year	-98.20%
Cash/sh	0.15	P/C	1.56	EPS next 5Y	-	ROE	-138.69%	52W Range	0.12 - 22.14	Perf YTD	-98.17%
Dividend Est.	-	P/FCF	-	EPS past 5Y	79.31%	ROI	-169.47%	52W High	-98.93%	Beta	2.23
Dividend TTM	-	Quick Ratio	2.78	Sales past 5Y	0.00%	Gross Margin	-18.28%	52W Low	99.92%	ATR (14)	0.02
Dividend Ex-Date	-	Current Ratio	3.33	EPS Y/Y TTM	-83.05%	Oper. Margin	-731.49%	RSI (14)	73.71	Volatility	10.66% 13.82%
Employees	103	Debt/Eq	0.12	Sales Y/Y TTM	183.05%	Profit Margin	-1197.86%	Recom	1.00	Target Price	25.25
Option/Short	No / Yes	LT Debt/Eq	0.08	EPS Q/Q	87.46%	Payout	-	Rel Volume	3.27	Prev Close	0.20
Sales Surprise	-10.41%	EPS Surprise	94.07%	Sales Q/Q	-29.26%	Earnings	Nov 12 BMO	Avg Volume	34.56M	Price	0.24
SMA20	29.84%	SMA50	43.69%	SMA200	-91.42%	Trades		Volume	39,458,841	Change	16.67%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-18-22	Initiated	Noble Capital Markets	Outperform
Apr-18-19	Upgrade	ROTH Capital	Neutral → Buy	$4
Aug-18-17	Upgrade	ROTH Capital	Neutral → Buy	$6
Sep-07-16	Downgrade	ROTH Capital	Buy → Neutral
Feb-17-16	Reiterated	Oppenheimer	Outperform	$18 → $10
Nov-04-15	Initiated	Cantor Fitzgerald	Buy
Jun-12-15	Initiated	Oppenheimer	Outperform	$18
Feb-17-15	Reiterated	ROTH Capital	Buy	$10 → $12
Sep-29-14	Reiterated	ROTH Capital	Buy	$17 → $10

Dec-09-24 07:30AM	Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers (ACCESSWIRE)
Dec-03-24 07:00AM	Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires (GlobeNewswire)
Nov-26-24 07:00AM	Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference (GlobeNewswire)
Nov-18-24 04:05PM	Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual (GlobeNewswire) +22.33%
07:00AM	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting (GlobeNewswire)
07:30AM	Loading…
Nov-14-24 07:30AM	Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments (ACCESSWIRE)
Nov-13-24 04:05PM	Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting (GlobeNewswire)
09:05AM	Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals (GlobeNewswire)
Nov-12-24 08:00AM	Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights (GlobeNewswire)
Nov-05-24 07:55AM	Tonix Pharma Partners for Vaccine Clinical Trial (TipRanks)
Nov-04-24 07:00AM	Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya (GlobeNewswire)
Nov-01-24 07:00AM	Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 (GlobeNewswire)
Oct-29-24 08:00AM	Tonix Pharmaceuticals to Present at BIO-Europe 2024 (GlobeNewswire) -6.15%
Oct-25-24 08:00AM	Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference (GlobeNewswire)
Oct-24-24 08:00AM	Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 (GlobeNewswire)
08:00AM	Loading…
Oct-17-24 08:00AM	Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) (GlobeNewswire) +12.83%
Oct-16-24 01:01PM	Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals (GuruFocus.com) +12.77%
08:00AM	Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) (GlobeNewswire)
Oct-09-24 07:28AM	Tonix Pharma Enhances Drug Development with AI Partnership (TipRanks)
Oct-08-24 08:30AM	Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals (GlobeNewswire)
Oct-01-24 01:31PM	AI Security, "Netflix of China", Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances (News Direct) -8.75%
07:30AM	The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions (ACCESSWIRE)
Sep-30-24 07:00AM	Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID) (GlobeNewswire)
Sep-27-24 07:00AM	Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace SymTouch to Treat Migraines (GlobeNewswire) +6.88%
Sep-23-24 07:00AM	Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) (GlobeNewswire) -8.54%
Sep-19-24 07:00AM	Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines (GlobeNewswire)
Sep-18-24 07:30AM	New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution (ACCESSWIRE)
Sep-16-24 07:00AM	Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency (GlobeNewswire) -5.93%
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
Sep-10-24 07:00AM	Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations (GlobeNewswire) -6.12%
07:00AM	Loading…
Sep-09-24 07:00AM	Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in Using Synthetic Biology to Battle Mpox Talk at Immunology Symposium at the University of Alberta (GlobeNewswire) +15.86%
Sep-06-24 07:00AM	Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek (GlobeNewswire) -10.26%
Sep-04-24 07:00AM	As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL (ACCESSWIRE)
Aug-29-24 07:00AM	Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -14.82%
Aug-28-24 07:00AM	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -17.37%
Aug-26-24 10:41AM	Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine (Benzinga) +10.00%
07:00AM	Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801 (GlobeNewswire)
Aug-23-24 07:45AM	Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency (ACCESSWIRE)
Aug-21-24 07:00AM	Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -5.26%
Aug-20-24 12:34PM	Tonix initiates Phase II trial for emergency cocaine intoxication treatment (Clinical Trials Arena) -14.61%
07:00AM	Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication (GlobeNewswire)
Aug-19-24 06:00AM	Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights (GlobeNewswire)
Aug-16-24 10:52PM	TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
01:29PM	Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests (Benzinga)
07:00AM	Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency (GlobeNewswire)
Aug-13-24 08:00AM	Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit (GlobeNewswire)
Aug-12-24 08:00AM	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain (GlobeNewswire) +7.00%
Aug-06-24 08:00AM	Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company's Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens (GlobeNewswire)
Aug-01-24 07:45AM	FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate (ACCESSWIRE)
Jul-31-24 08:00AM	Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya (GlobeNewswire) -12.23%
Jul-30-24 08:00AM	Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain (GlobeNewswire)
Jul-29-24 09:00AM	Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program (PR Newswire)
Jul-25-24 08:30AM	Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected (GlobeNewswire) +9.96%
08:00AM	Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya for Fibromyalgia (GlobeNewswire)
Jul-24-24 07:45AM	Beyond 'One Bug, One Drug' - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral (ACCESSWIRE) -7.19%
Jul-22-24 07:00AM	7 Sorry Biotech Stocks Set to Make Investors Sad (InvestorPlace)
Jul-19-24 12:48PM	Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence (News Direct)
Jul-18-24 10:20AM	Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya for fibromyalgia management (News Direct)
Jul-17-24 08:00AM	Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025 (ACCESSWIRE)
Jul-10-24 04:30PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire)
Jul-09-24 09:15AM	Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering (GlobeNewswire) -15.47%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-08-24 05:00PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire) -10.96%
08:00AM	Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya for the Management of Fibromyalgia (GlobeNewswire)
07:00AM	7 F-Rated Stocks To Sell in July (InvestorPlace)
Jul-01-24 11:07AM	Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract (Benzinga)
08:00AM	Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program (GlobeNewswire)
Jun-28-24 04:05PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire)
Jun-27-24 11:01AM	AMZN Stock Alert: Amazon Just Joined the $2 Trillion Club (InvestorPlace) -38.67%
08:37AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today? (InvestorPlace)
08:36AM	Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering (GlobeNewswire)
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-26-24 04:40PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire) -10.00%
03:13PM	Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jun-25-24 08:00AM	Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 (GlobeNewswire) +5.04%
Jun-21-24 07:30AM	7 F-Rated Penny Stocks to Avoid This June (InvestorPlace)
Jun-20-24 08:00AM	Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya for the Management of Fibromyalgia (GlobeNewswire) +10.66%
Jun-18-24 12:31PM	Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 (InvestorPlace) +8.93%
08:00AM	Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) (GlobeNewswire)
Jun-17-24 08:00AM	Tonix Pharmaceuticals Presented Poster of Tonmya for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024 (GlobeNewswire)
Jun-13-24 05:00PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire) +5.50%
Jun-12-24 10:06AM	FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts (InvestorPlace) -47.89%
09:00AM	Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering (GlobeNewswire)
08:52AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today? (InvestorPlace)
07:46AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jun-11-24 05:17PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire)
10:26AM	Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management (News Direct)
Jun-10-24 12:14PM	SOUN Stock Alert: SoundHound AI Pays Off Debt Early (InvestorPlace) -33.66%
11:55AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today? (InvestorPlace)
Jun-06-24 11:00AM	Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split (GlobeNewswire) -28.04%
08:00AM	Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 (GlobeNewswire)
Jun-05-24 08:00AM	Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024 (GlobeNewswire)
Jun-03-24 08:00AM	Tonix Pharmaceuticals Presented New Data on Tonmya Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting (GlobeNewswire)
May-30-24 08:00AM	Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting (GlobeNewswire)
May-29-24 08:00AM	Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 (GlobeNewswire)
May-28-24 08:00AM	Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention (GlobeNewswire)
May-22-24 08:00AM	Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting (GlobeNewswire)
May-21-24 08:00AM	Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya for the Management of Fibromyalgia (GlobeNewswire)
May-20-24 10:53AM	TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-15-24 08:00AM	Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase (GlobeNewswire)

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TNXP

Tonix Pharmaceuticals Holding Corp

Upgrade your FINVIZ experience